Modest interventions deliver significant results in cholesterol management.
Countless studies have proven the value of lipid-lowering therapy in managing cholesterol levels, but for a variety for reasons, under-treatment of hyperlipidemia is widespread--even among patients who have already suffered from at least one adverse cardiac event. Fortunately, however, the problem may not be that difficult to fix. New research suggests that even modest DM interventions can have a big impact on outcomes and downstream costs.